News & Blog

News & Blog

| Mar 19 2023

Repeat associated non-AUG (RAN) proteins in FA: contribution to disease and therapeutic opportunities

| Dec 19 2022

TGFβ signaling activity as disease biomarkers and therapeutic targets in Friedreich’s Ataxia

| Oct 19 2022

Illuminating how SynGRs liberate gene expression from heterochromatin

| Sep 19 2022

Calcium communication among intracellular compartments in FA patient-derived cells

| Jun 19 2022

Rescue of Friedreich’s Ataxia cells by DNA methylation editing of the FXN gene

| Apr 19 2022

Novel Mitochondrial Targets for Friedreich’s Ataxia

| Mar 19 2022

Understanding ketogenesis in FRDA: Pathophysiology, biomarkers and nutritional therapies

| Jan 19 2022

Investigating epigenetic silencing in Friedreich’s Ataxia

| Oct 19 2021

Sphingolipid rheostat as a potential target for Friedreich’s Ataxia

| Oct 19 2021

Pathophysiology of Muscle Dysfunction in Friedreich’s Ataxia

| Jul 19 2021

Assessment of early somatosensory impairment in the KIKO mouse model of Friedreich’s Ataxia

| Apr 19 2021

Hepcidin-Ferroportin axis in Friedreich’s Ataxia